Duck Interleukin 6,IL-6 ELISA Kit
- Known as:
- Duck Interleukin 6,Interleukin-6 Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- kn0015du
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Kono Biotech
- Gene target:
- Duck Interleukin 6 IL-6 ELISA Kit
Ask about this productRelated genes to: Duck Interleukin 6,IL-6 ELISA Kit
- Gene:
- CEBPB NIH gene
- Name:
- CCAAT enhancer binding protein beta
- Previous symbol:
- TCF5
- Synonyms:
- LAP, CRP2, NFIL6, IL6DBP, C/EBP-beta
- Chromosome:
- 20q13.13
- Locus Type:
- gene with protein product
- Date approved:
- 1991-02-27
- Date modifiied:
- 2018-02-23
- Gene:
- CEBPD NIH gene
- Name:
- CCAAT enhancer binding protein delta
- Previous symbol:
- -
- Synonyms:
- CRP3, CELF, C/EBP-delta, NF-IL6-beta
- Chromosome:
- 8q11.21
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-24
- Date modifiied:
- 2018-02-23
- Gene:
- ENTPD6 NIH gene
- Name:
- ectonucleoside triphosphate diphosphohydrolase 6
- Previous symbol:
- CD39L2, IL6ST2
- Synonyms:
- NTPDase-6, dJ738P15.3
- Chromosome:
- 20p11.21
- Locus Type:
- gene with protein product
- Date approved:
- 1998-03-20
- Date modifiied:
- 2019-02-28
- Gene:
- IL6 NIH gene
- Name:
- interleukin 6
- Previous symbol:
- IFNB2
- Synonyms:
- IL-6, BSF2, HGF, HSF
- Chromosome:
- 7p15.3
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2017-07-12
- Gene:
- IL6RP1 NIH gene
- Name:
- interleukin 6 receptor pseudogene 1
- Previous symbol:
- IL6RL1
- Synonyms:
- -
- Chromosome:
- 9q22.2
- Locus Type:
- pseudogene
- Date approved:
- 1991-08-18
- Date modifiied:
- 2014-11-19
Related products to: Duck Interleukin 6,IL-6 ELISA Kit
Related articles to: Duck Interleukin 6,IL-6 ELISA Kit
- Disease-modifying anti-rheumatic drugs (DMARDs) are essential in managing inflammatory arthritides such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA). As total hip arthroplasty (THA) and DMARD use become more common, it is unclear how DMARD use affects outcomes in this population. This study compared complications and implant survivorship after THA in patients who have inflammatory arthritis who had and did not have DMARD treatment. - Source: PubMed
Publication date: 2026/04/17
Sheth NigamRoss Bailey JHrudka BryceNezameslami AhmadrezaMathews DavidCulley JenniferWilson Jacob MPremkumar Ajay - The clinical application of dihydroartemisinin (DHA) is limited by its pharmacokinetic profile, making high in vitro concentrations clinically unattainable. Its effects at physiologically relevant low doses, especially in the complex tumor microenvironment (TME), are poorly understood. - Source: PubMed
Ruan JieYin JinbaoZeng XuanLiu FagangWang Zhiyong - To compare the therapeutic effects of intravenous (IV) and intratracheal (IT) delivery of adipose-derived stem cells (ADSCs) in a mouse model of bleomycin (BLM)-induced idiopathic pulmonary fibrosis (IPF). - Source: PubMed
Publication date: 2026/02/28
Ng Yan-YanChiang Chen-YuNi Yung-LunShen Huan-TingLee Chien-YingLee Tai-PingSieber MartinTseng Ching-ChiTsao Thomas Chang-YaoKuan Yu-Hsiang - Pulmonary arterial hypertension (PAH) involves progressive obstruction of small pulmonary vessels due to vascular remodeling. Although the genetic architecture of PAH is increasingly understood, it remains poorly characterized in Algeria due to limited studies and the absence of molecular diagnostic infrastructure. - Source: PubMed
Publication date: 2026/04/16
Berkane Amel WafaYahiaoui RachidaMethia NadéraDjami-Temim NassimaCoulet FlorenceAntigny FabriceMontani DavidHamouli-Said Zohra - This study investigated the role of TGF-β-activated kinase 1 (TAK1) in synovial inflammation and hyperplasia in JIA synovial fibroblasts (JIASFs). - Source: PubMed
Publication date: 2026/04/17
Shanta Meena ALough Donavon CHenderson Lauren ANigrovic Peter AAhmed Salahuddin